Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00752739 · ClinicalTrials.gov registry record · Phase 2
Selenium in Treating Patients With Prostate Cancer
A Phase 2 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 220
- Enrollment target
NCT00752739 is a Phase 2 study that has completed, run by University of Arizona. The registered enrollment target is 220 participants.
The verdict
NCT00752739, a Phase 2 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 220 participants
- Enrollment target
Study Summary
RATIONALE: Selenium may prevent or slow the growth of prostate cancer. PURPOSE: This randomized phase II trial is studying how well selenium works in treating patients with prostate cancer.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT selenium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2002-08 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00752739
The ClinicalTrials.gov registry entry for NCT00752739 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00752739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00752739 about?
NCT00752739 is a clinical study titled "Selenium in Treating Patients With Prostate Cancer". RATIONALE: Selenium may prevent or slow the growth of prostate cancer. PURPOSE: This randomized phase II trial is studying how well selenium works in treating patients with prostate cancer.
What is the current status of trial NCT00752739?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 2002-08. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00752739?
The interventions under investigation include: placebo (OTHER), selenium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00752739?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.